FDA.reportPublic FDA data

Minivelle 0.075 MG/Day Twice Weekly Transdermal System

RxCUI
1357007
RxNorm name
Minivelle 0.075 MG/Day Twice Weekly Transdermal System
Display name
Minivelle 0.075 MG/Day Twice Weekly Transdermal System
Full name
Minivelle 0.075 MG/Day Twice Weekly Transdermal System
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MinivelleESTRADIOLNoven Therapeutics, LLC6c5c47ab-28ee-11e1-bfc2-0800200c9a662026-07-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1357007

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6c5c47ab-28ee-11e1-bfc2-0800200c9a66Minivelle 0.075 MG/Day Twice Weekly Transdermal System [PSN] · 84 HR estradiol 0.00313 MG/HR Transdermal System [Minivelle] [SBD] · 84 HR Minivelle 0.00313 MG/HR Transdermal System [SY] · Minivelle 0.075 MG per 24HR Twice Weekly Transdermal Patch [SY] · Minivelle 0.075 MG/Day Twice Weekly Transdermal System [SY]519These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222